A novel composite formulation of palmitoylethanolamide and quercetin decreases inflammation and relieves pain in inflammatory and osteoarthritic pain models

BACKGROUND: Osteoarthritis (OA) is a common progressive joint disease in dogs and cats. The goal of OA treatment is to reduce inflammation, minimize pain, and maintain joint function. Currently, non-steroidal anti-inflammatory drugs (e.g., meloxicam) are the cornerstone of treatment for OA pain, but...

Descripción completa

Detalles Bibliográficos
Autores principales: Britti, Domenico, Crupi, Rosalia, Impellizzeri, Daniela, Gugliandolo, Enrico, Fusco, Roberta, Schievano, Carlo, Morittu, Valeria Maria, Evangelista, Maurizio, Di Paola, Rosanna, Cuzzocrea, Salvatore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541643/
https://www.ncbi.nlm.nih.gov/pubmed/28768536
http://dx.doi.org/10.1186/s12917-017-1151-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541643/
https://www.ncbi.nlm.nih.gov/pubmed/28768536
http://dx.doi.org/10.1186/s12917-017-1151-z

Ejemplares similares